It is assumed that hypoalbuminemia in COVID-19 develops not only due to the damage to the hepatocellular system but also as a result of systemic inflammation and increased capillary permeability, which causes albumin to disappear into the interstitium [18]. The gene discussed is ALB; the disease is COVID-19.